• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在Wistar大鼠中建立肝细胞癌实验性植入瘤模型。

Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.

作者信息

Jin Yi, Tong Dayue, Shen Junjie, Yang Jianyong, Li Jiaping

机构信息

Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

出版信息

Tumour Biol. 2014 Sep;35(9):9079-83. doi: 10.1007/s13277-014-2161-0. Epub 2014 Jun 7.

DOI:10.1007/s13277-014-2161-0
PMID:24913708
Abstract

Our aims were to investigate and establish simple and reliable implanted hepatocellular carcinoma (HCC) models in Wistar rats. Concentrated suspensions of CBRH-7919 cancer cell lines were injected subcutaneously into the scapular regions of nude mice. The developing tumor tissues were then implanted into the livers of 45 adult Wistar rats. Dexamethasone (2.5 mg/day) was injected intramuscularly daily for 1 week preoperatively and 2 weeks postoperatively. After 4 weeks of implantation, ultrasonography and nuclear magnetic resonance imaging (MRI) were performed to identify model rats with liver tumor growth and to analyze the growth and characteristics of the tumors. Five of these model rats were then sacrificed, and the tumors were removed from the liver for pathological examination. Three rats died during the operation; among the remaining 42 rats, 36 possessed a total of 43 liver tumors. The success rate of tumor implantation was 85.7 % (36/42), and the diameters of the tumors ranged from 5 to 10 mm. All tumor specimens were confirmed to be HCC by pathological examination. This study provides a new approach for establishing implanted HCC models in Wistar rats, which can be used for studying numerous biological features of HCC.

摘要

我们的目的是研究并建立Wistar大鼠简单可靠的植入性肝细胞癌(HCC)模型。将CBRH-7919癌细胞系的浓缩悬液皮下注射到裸鼠肩胛区域。然后将生长的肿瘤组织植入45只成年Wistar大鼠的肝脏。术前1周和术后2周每天肌肉注射地塞米松(2.5mg/天),持续1周。植入4周后,进行超声检查和核磁共振成像(MRI),以识别有肝肿瘤生长的模型大鼠,并分析肿瘤的生长情况和特征。然后处死其中5只模型大鼠,将肿瘤从肝脏中取出进行病理检查。手术中有3只大鼠死亡;在其余42只大鼠中,36只共有43个肝肿瘤。肿瘤植入成功率为85.7%(36/42),肿瘤直径为5至10mm。所有肿瘤标本经病理检查均确诊为HCC。本研究为在Wistar大鼠中建立植入性HCC模型提供了一种新方法,可用于研究HCC的多种生物学特性。

相似文献

1
Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.在Wistar大鼠中建立肝细胞癌实验性植入瘤模型。
Tumour Biol. 2014 Sep;35(9):9079-83. doi: 10.1007/s13277-014-2161-0. Epub 2014 Jun 7.
2
Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.肝内组织植入是建立原位移植肝癌小鼠模型的一种良好方法。
PLoS One. 2016 Jan 29;11(1):e0148263. doi: 10.1371/journal.pone.0148263. eCollection 2016.
3
[Establishment and biological characteristics of orthotopic transplantation tumor model of hepatocellular carcinoma in mice].[小鼠肝癌原位移植瘤模型的建立及生物学特性]
Zhong Xi Yi Jie He Xue Bao. 2004 Sep;2(5):372-4. doi: 10.3736/jcim20040518.
4
Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.建立小鼠原位移植肝癌肿瘤模型。
World J Gastroenterol. 2012 Dec 21;18(47):7087-92. doi: 10.3748/wjg.v18.i47.7087.
5
Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.经皮超声引导下植入VX2建立兔肝肿瘤模型。
PLoS One. 2015 Apr 8;10(4):e0123888. doi: 10.1371/journal.pone.0123888. eCollection 2015.
6
Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.通过体内筛选建立具有独特转移特性的肝癌细胞系,并通过cDNA微阵列筛选转移相关基因。
J Cancer Res Clin Oncol. 2003 Jan;129(1):43-51. doi: 10.1007/s00432-002-0396-4. Epub 2002 Dec 4.
7
Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.脂肪肝通过激活肝星状细胞为肝细胞癌创造了一个促转移的微环境。
Int J Cancer. 2015 Feb 15;136(4):E3-13. doi: 10.1002/ijc.29096. Epub 2014 Aug 4.
8
Establishment of a dual-color fluorescence tracing orthotopic transplantation model of hepatocellular carcinoma.建立肝癌双色荧光示踪原位移植模型。
Mol Med Rep. 2016 Jan;13(1):762-8. doi: 10.3892/mmr.2015.4624. Epub 2015 Nov 30.
9
[Establishment of a high metastatic potential human hepatocellular carcinoma orthotopic transplantation model with palliative liver resection in nude mice].[建立裸鼠姑息性肝切除术后高转移潜能人肝细胞癌原位移植模型]
Zhonghua Gan Zang Bing Za Zhi. 2013 Aug;21(8):604-8. doi: 10.3760/cma.j.issn.1007-3418.2013.08.010.
10
[Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].经脾内转染白细胞介素-12与白细胞介素-2融合基因治疗肝细胞癌的实验研究
Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):740-3.

引用本文的文献

1
Effects of sinomenine on a rat orthotopic liver carcinoma model.盐酸青藤碱对大鼠原位肝癌模型的影响。
Histol Histopathol. 2024 Jun;39(6):795-804. doi: 10.14670/HH-18-683. Epub 2023 Nov 30.
2
Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.载有蟾蜍灵的牛血清白蛋白纳米粒对肝癌显示出增强的抗肿瘤活性:制备、表征、药代动力学及组织分布
Oncotarget. 2017 Jun 28;8(38):63311-63323. doi: 10.18632/oncotarget.18800. eCollection 2017 Sep 8.
3
In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography.

本文引用的文献

1
Current management of hepatocellular carcinoma.肝细胞癌的当前管理
Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61.
2
Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.肝细胞癌联合分子靶向治疗与局部区域治疗的临床试验:过去、现在与未来
Liver Cancer. 2014 Mar;3(1):9-17. doi: 10.1159/000343854.
3
Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.组织微环境作为肝细胞癌治疗靶点的作用
使用超声成像技术对啮齿动物骨骼肌萎缩进行的体内纵向研究。
Sci Rep. 2016 Feb 1;6:20061. doi: 10.1038/srep20061.
World J Gastroenterol. 2014 Apr 21;20(15):4128-40. doi: 10.3748/wjg.v20.i15.4128.
4
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.肝硬化患者肝细胞癌监测的早期检测、治愈治疗和生存率:一项荟萃分析。
PLoS Med. 2014 Apr 1;11(4):e1001624. doi: 10.1371/journal.pmed.1001624. eCollection 2014 Apr.
5
Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus.与肝炎病毒相关的肝细胞癌根治性切除术后的辅助治疗
Liver Cancer. 2013 Jan;2(1):40-6. doi: 10.1159/000346214.
6
HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.HLA 和杀伤细胞免疫球蛋白样受体基因作为丙型肝炎病毒相关肝细胞癌的预后预测因子。
Clin Cancer Res. 2013 Oct 1;19(19):5465-73. doi: 10.1158/1078-0432.CCR-13-0986. Epub 2013 Aug 12.
7
Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.非乙型和非丙型肝炎病毒相关肝细胞癌与乙型肝炎病毒和丙型肝炎病毒相关肝细胞癌患者手术后临床特征和生存的比较。
J Cancer. 2013 Jul 18;4(6):502-13. doi: 10.7150/jca.6503. Print 2013.
8
Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.HBV 相关肝细胞癌中人类肝星状细胞的临床意义及基因表达研究。
J Exp Clin Cancer Res. 2013 Apr 19;32(1):22. doi: 10.1186/1756-9966-32-22.
9
Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.建立小鼠原位移植肝癌肿瘤模型。
World J Gastroenterol. 2012 Dec 21;18(47):7087-92. doi: 10.3748/wjg.v18.i47.7087.
10
Experimental mouse models for hepatocellular carcinoma research.用于肝细胞癌研究的实验小鼠模型。
Int J Exp Pathol. 2009 Aug;90(4):367-86. doi: 10.1111/j.1365-2613.2009.00656.x.